Pathological complete response after neoadjuvant treatment determines survival in esophageal squamous cell carcinoma patients (NEOCRTEC5010).
Shen J, Kong M, Yang H, Jin K, Chen Y, Fang W, Yu Z, Mao W, Xiang J, Han Y, Chen Z, Yang H, Wang J, Pang Q, Zheng X, Yang H, Li T, Zhang X, Li Q, Wang G, Mao T, Guo X, Lin T, Liu M, Ma D, Ye M, Wang C, Wang Z, Brunelli A, Cerfolio RJ, D'Journo XB, Fernando HC, Lordick F, Fu J, Chen B, Zhu C; written on behalf of the AME Thoracic Surgery Collaborative Group.
Shen J, et al. Among authors: kong m.
Ann Transl Med. 2021 Oct;9(20):1516. doi: 10.21037/atm-21-3331.
Ann Transl Med. 2021.
PMID: 34790722
Free PMC article.